Healthcare (Medicare)

in committee · United States · House Sep 26, 2025

HR 5592: Childhood Genital Mutilation Prevention Act

HR 5592, the Childhood Genital Mutilation Prevention Act, prohibits medical procedures related to gender identity for minors under 18, with exceptions for treating specific medical conditions like disorders of sex development or injuries. It criminalizes performing such treatments under certain circumstances (e.g., involving interstate commerce) with penalties up to 10 years in prison, while exempting care for diagnosed medical needs. The bill also excludes these procedures from Medicare/Medicaid coverage after 90 days and bans federal funding for such treatments or related health coverage. This directly affects minors under 18, healthcare providers, and insurers offering these services, but allows exceptions for medically necessary care.

Topics ✗ Criminal JusticeOpposes Criminal JusticeCriminalizes medical procedures for minors with prison penalties, expanding criminalization per indicators.85% confidence ✗ HealthcareOpposes HealthcareRestricts gender-affirming medical care for minors under 18, criminalizing procedures except for diagnosed medical conditions, limiting access to healthcare services.95% confidence

Sub-Topics Corrections Medicaid Medicare

Track

in committee · United States · House Jun 20, 2025

HR 4056: RAMP Act

Repair Abuses of MSP Payments Act or the RAMP Act This bill restricts the private right of action against insurance plans that do not provide appropriate primary payment in cases in which Medicare is a secondary payer. Current law allows for a private right of action against primary plans that do not provide appropriate primary payment in cases in which Medicare is a secondary payer; this provision applies to group health plans, workers' compensation plans, automobile or liability insurance plans, and no-fault insurance plans. The bill limits this provision to group health plans.

Topics ✗ HealthcareOpposes HealthcareBill restricts private lawsuits against insurers for Medicare secondary payer payment errors, reducing patient access to compensation for coverage disputes in healthcare insurance.90% confidence

Sub-Topics Medicare

Track

in committee · United States · House Nov 20, 2025

HR 6225: PAUSE Act of 2025

This bill would pause most visa issuances and immigration status approvals until specific conditions are met under immigration law. It prohibits access to public schools for unauthorized immigrants, restricts citizenship eligibility to children born in the U.S. with at least one U.S. citizen or permanent resident parent, and bars certain benefits like Medicare, food assistance, and student loans for most non-citizens. The bill also imposes a $100,000 fee on H-1B work visa applications starting in 2026, terminates the Optional Practical Training program for international students, and repeals the Diversity Visa lottery program. These provisions directly affect immigrants seeking visas, students, and applicants for specific immigration pathways.

Topics ✗ EducationOpposes EducationProhibits unauthorized immigrants from public schools and bars student loans for non-citizens, restricting educational access and financial aid.95% confidence ✗ HealthcareOpposes HealthcareBars Medicare access for non-citizens, restricting healthcare coverage and benefits as explicitly stated in the bill summary.95% confidence ✗ ImmigrationOpposes ImmigrationRestricts public school access, citizenship eligibility, benefits, and imposes high H-1B fees, clearly limiting immigrant rights and services.90% confidence

Sub-Topics Medicare Citizenship & Naturalization DACA & Dreamers Work Authorization

Track

in committee · United States · Senate Mar 4, 2025

S 832: EPIC Act of 2025

The EPIC Act of 2025 extends the required time period for negotiating drug prices under the federal program for biologic drugs. It changes the rule so that biologic drug manufacturers must wait at least 11 years after FDA approval before their drug can be included in price negotiations, starting with the 2028 initial price applicability year. This specifically affects biologic drug manufacturers, as the change applies only to biologics (not small-molecule drugs, which already have different rules). The bill modifies Section 1192(e)(1)(A)(ii) of the Social Security Act to implement this longer waiting period. This is a concrete policy change to the timing of drug price negotiations, not a new program or broader policy shift.

Topics ✗ HealthcareOpposes HealthcareExtends 11-year wait for biologic drug price negotiations, delaying cost reductions and maintaining higher drug prices, restricting patient access and increasing healthcare costs.92% confidence

Sub-Topics Medicaid Medicare Prescription Drugs

Track

in committee · United States · House Jan 2, 2026

HR 6937: End H-1B Now Act

This bill would gradually phase out the H-1B visa program, reducing annual caps from 10,000 in fiscal year 2026 to zero by 2035. It eliminates H-1B eligibility for fashion models, requires applicants to maintain foreign residence, and restricts specialty occupation visas to only physicians, surgeons, and nurses. Additionally, the bill prohibits Medicare funding for medical residency programs training foreign nationals. These changes directly affect foreign workers seeking H-1B visas, employers who sponsor them, and healthcare training programs receiving federal funding.

Topics ✗ HealthcareOpposes HealthcareProhibits Medicare funding for medical residency programs training foreign nationals, directly defunding healthcare workforce development for physicians and nurses.90% confidence ✗ ImmigrationOpposes ImmigrationPhases out H-1B visas, restricts specialty occupation access, and eliminates foreign worker training funding - directly limiting immigrant work opportunities and access to services.95% confidence

Sub-Topics Medicare Enforcement

Track

in committee · United States · Senate Mar 14, 2025

S 1082: Safeguarding Medicaid Act

The Safeguarding Medicaid Act (S 1082) requires all Medicaid applicants and recipients in every state and territory to undergo an asset test, removing previous exemptions for people who are aged, blind, or disabled. It sets the resource limit for eligibility at the same level used for Supplemental Security Income (SSI) benefits, meaning individuals with assets above this threshold would be ineligible for Medicaid. The bill also mandates states to implement electronic asset verification systems within one year of enactment and report annually on the number of asset checks conducted during eligibility renewals and new applications. This affects all Medicaid applicants and recipients nationwide, with states required to track and report savings from these verification efforts to the federal government.

Topics ✗ HealthcareOpposes HealthcareRemoves exemptions for aged/blind/disabled Medicaid recipients, imposes strict SSI-level asset limits, restricting healthcare access for vulnerable populations.95% confidence

Sub-Topics Medicaid Medicare

Track

in committee · United States · Senate Feb 24, 2025

S 694: PLASMA Act

The PLASMA Act (S 694) modifies Medicare Part D drug discount rules for plasma-derived products - biological drugs made from human blood plasma. It establishes a phased reduction in the discount rate these drugs must offer to Medicare beneficiaries, starting at 99% of the negotiated price in 2026 and gradually decreasing to 80% by 2032. This affects manufacturers of plasma-derived drugs covered under Medicare Part D and beneficiaries who meet specific out-of-pocket cost thresholds. The bill excludes certain low-income beneficiaries and small manufacturers from these provisions. The policy change directly alters how drug costs are calculated for these specific medications under Medicare.

Topics ✗ HealthcareOpposes HealthcareBill reduces Medicare Part D discounts for plasma drugs from 99% to 80% by 2032, increasing beneficiary out-of-pocket costs and restricting access to affordable treatments.85% confidence

Sub-Topics Medicare Prescription Drugs

Track

in committee · United States · Senate Jan 9, 2025

S 62: America First Act

The America First Act would restrict eligibility for numerous federal benefit programs based on immigration status. It requires verification of citizenship or lawful immigration status for programs including Medicaid, Medicare, Head Start, school meals, WIC, the Child Tax Credit, Earned Income Tax Credit, and housing assistance. The bill specifically would deny benefits to individuals who are unlawfully present in the U.S. or who have certain immigration statuses including parolees, Temporary Protected Status (TPS) recipients, DACA recipients, and asylum seekers. These provisions would directly affect millions of immigrants and their families who currently qualify for these programs. The bill would also prohibit use of FEMA assistance for certain non-citizens and limit access to postsecondary financial aid based on immigration status.

Topics ✗ Budget & TaxesOpposes Budget & TaxesRestricts eligibility for federal benefits including tax credits (EITC), reducing government spending on programs like Medicaid and WIC.95% confidence ✗ EducationOpposes EducationRestricts school meal and Head Start access by denying benefits to immigrants, limiting educational access for affected students95% confidence ✗ HealthcareOpposes HealthcareRestricts Medicaid, Medicare, and WIC eligibility for undocumented immigrants, directly limiting access to healthcare benefits and public health programs.95% confidence ✗ HousingOpposes HousingDenies housing assistance to undocumented immigrants and parolees, restricting access to federal housing benefits95% confidence ✗ ImmigrationOpposes ImmigrationRestricts federal benefits for undocumented and certain immigrant statuses, denying access to Medicaid, housing assistance, and other programs per bill summary.95% confidence

Sub-Topics Income Tax Tax Credits Early Childhood Student Financial Aid Student Health Medicaid Medicare Community Development Property Development Citizenship & Naturalization DACA & Dreamers Work Authorization

Track

in committee · United States · House Jun 3, 2025

HR 3467: To amend title XVIII to reform the Medicare Advantage program.

HR 3467 reforms Medicare Advantage (MA) by requiring most plans to use fixed payments per member (capitated payments) starting in 2028, with exceptions for existing plans and special needs plans. It modifies payments by reducing blended benchmarks, changing how health status risk adjustments are calculated (using only face-to-face/telehealth diagnoses), and eliminating quality-based payment increases. The bill mandates automatic enrollment into the lowest-premium MA plan for eligible beneficiaries starting in 2028, with a 3-year enrollment lock-in period unless a hardship event occurs. Additionally, it requires MA plans to include hospice care coverage (with a 2028 transition exception) and adds an exception for durable medical equipment and Part D drugs under the Stark Law.

Topics ✗ HealthcareOpposes HealthcareBill reduces blended benchmarks, eliminates quality-based payments, and mandates lower-premium enrollment, likely restricting Medicare Advantage benefits and program funding.85% confidence

Sub-Topics Insurance Medicare Telehealth

Track

in committee · United States · House Mar 6, 2025

HR 1922: Ensuring Access to Essential Drugs Act

This bill exempts certain orally administered drugs from Medicare Part D's manufacturer discount program. Specifically, it excludes drugs that: (1) received FDA approval under the standard new drug application process, and (2) have been granted a narrow CMS exception allowing them to be treated as noninnovator drugs under Medicaid rebates. The exemption applies directly to these specific drugs meeting both criteria, altering how their costs are calculated under Medicare Part D. This change affects drug manufacturers and Medicare beneficiaries by modifying the discount structure for these particular medications.

Topics ✗ HealthcareOpposes HealthcareExempts specific drugs from Medicare Part D discounts, likely increasing costs for beneficiaries and restricting access to essential drugs.85% confidence

Sub-Topics Medicaid Medicare Prescription Drugs

Track